Regulating A549 cells growth by ASO inhibiting miRNA expression

Molecular and Cellular Biochemistry

Volumn 339, Issue 1-2, 2010, Pages 163-171

  Wang, Ping Yu ^a   Li, You Jie ^a   Zhang, Shuai ^a   Li, Zun Ling ^a   Yue, Zhen ^a   Xie, Ning ^b   Xie, Shu Yang ^a  

^a Binzhou Medical University   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antisense oligonucleotides; Apoptosis; Chemotherapy; Gene expression; MiRNAs

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; MICRORNA; NORCANTHARIDIN; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA 1 PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL PROLIFERATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG ADENOCARCINOMA; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77952292883     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0380-2     Document Type: Article

References (46)

1. B Kusenda M Mraz J Mayer S Pospisilova 2006 MicroRNA biogenesis, functionality and cancer relevance Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150 205 215 1:CAS:528:DC%2BD2sXjtFyrurw%3D 17426780
2. RF Place LC Li D Pookot EJ Noonan R Dahiya 2008 MicroRNA-373 induces expression of genes with complementary promoter sequences Proc Natl Acad Sci USA 105 1608 1613 10.1073/pnas.0707594105 1:CAS:528:DC%2BD1cXhvFCitbs%3D 18227514 (Pubitemid 351346562)
3. S Vasudevan Y Tong JA Steitz 2007 Switching from repression to activation: microRNAs can up-regulate translation Science 318 1931 1934 10.1126/science.1149460 1:CAS:528:DC%2BD2sXhsVGjsLbK 18048652
4. R Schickel B Boyerinas SM Park ME Peter 2008 MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Oncogene 27 5959 5974 10.1038/onc.2008.274 1:CAS:528:DC%2BD1cXhtF2msbbP 18836476
5. NC Lau LP Lim EG Weinstein DP Bartel 2001 An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans Science 294 858 862 10.1126/science.1065062 1:CAS:528:DC%2BD3MXotVChurw%3D 11679671 (Pubitemid 33032104)
6. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 281 297 10.1016/S0092-8674(04)00045-5 1:CAS:528:DC%2BD2cXhtVals7o%3D 14744438 (Pubitemid 38167318)
7. S Zhu H Wu F Wu D Nie S Sheng YY Mo 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Res 18 350 359 10.1038/cr.2008.24 1:CAS:528:DC%2BD1cXivVyjsb8%3D 18270520 (Pubitemid 351333899)
8. L Ma J Teruya-Feldstein RA Weinberg 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 682 688 10.1038/nature06174 1:CAS:528:DC%2BD2sXhtFChurfF 17898713 (Pubitemid 47552092)
9. PT Ho DR Parkinson 1997 Antisense oligonucleotides as therapeutics for malignant diseases Semin Oncol 24 187 202 1:CAS:528:DyaK2sXjtFKmurg%3D 9129689
10. ST Crooke 1998 Molecular mechanisms of antisense drugs: RNase H Antisense Nucleic Acid Drug Dev 8 133 134 1:CAS:528:DyaK1cXivFKgtL0%3D 9593052
11. RA Stahel U Zangemeister-Wittke 2003 Antisense oligonucleotides for cancer therapy-an overview Lung Cancer 41 S81 S88 10.1016/S0169-5002(03)00147-8 12867066 (Pubitemid 36818999)
12. V Wacheck U Zangemeister-Wittke 2006 Antisense molecules for targeted cancer therapy Crit Rev Oncol Hematol 59 65 73 10.1016/j.critrevonc.2005.10.004 1:STN:280:DC%2BD28zmvFOisw%3D%3D 16750913 (Pubitemid 43903274)
13. R Visone CM Croce 2009 MiRNAs and cancer Am J Pathol 174 1131 1138 10.2353/ajpath.2009.080794 1:CAS:528:DC%2BD1MXksVOksL0%3D 19264914
14. H Ren L Tian Q Gu W Zhu 2006 Secalonic acid D; A cytotoxic constituent from marine lichen-derived fungus Gliocladium sp. T31 Arch Pharm Res 29 59 63 10.1007/BF02977469 1:CAS:528:DC%2BD28XitVOmt74%3D 16491844
15. DJ O'Donovan JP Katkin T Tamura CV Smith SE Welty 2000 Attenuation of hyperoxia-induced growth inhibition in H441 cells by gene transfer of mitochondrially targeted glutathione reductase Am J Respir Cell Mol Biol 22 732 738 10837371
16. PJ Trotter MA Orchard JH Walker 1995 Ca2+ concentration during binding determines the manner in which annexin V binds to membranes Biochem J 308 591 598 1:CAS:528:DyaK2MXmtFersLw%3D 7772046
17. T Fan R Li NW Todd Q Qiu HB Fang H Wang, et al. 2007 Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target Cancer Res 67 7901 7906 10.1158/0008-5472.CAN-07-0090 1:CAS:528:DC%2BD2sXptVGlt7k%3D 17699796 (Pubitemid 47281386)
18. P Videhult J Yachnin E Jerremalm R Lewensohn H Ehrsson 2002 Synthesis and cytotoxicity of the dihydrated complex of oxaliplatin Cancer Lett 80 191 194 10.1016/S0304-3835(02)00002-2 (Pubitemid 34327373)
19. T Efferth R Rauh S Kahl M Tomicic H Böchzelt ME Tome, et al. 2005 Molecular modes of action of cantharidin in tumor cells Biochem Pharmacol 69 811 818 10.1016/j.bcp.2004.12.003 1:CAS:528:DC%2BD2MXhtlCrsb0%3D 15710358 (Pubitemid 40248623)
20. KK To YP Ho SC Au-Yeung 2005 Synergistic interaction between platinum-based antitumor agents and demethylcantharidin Cancer Lett 223 227 237 10.1016/j.canlet.2004.10.036 1:CAS:528:DC%2BD2MXkt1GhtLY%3D 15896457 (Pubitemid 40719621)
21. AM Cheng MW Byrom J Shelton LP Ford 2005 Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis Nucleic Acids Res 33 1290 1297 10.1093/nar/gki200 1:CAS:528:DC%2BD2MXit1Knu7s%3D 15741182 (Pubitemid 41439922)
22. A van den Berg BJ Kroesen K Kooistra D de Jong J Briggs T Blokzijl, et al. 2003 High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma Genes Chromosomes Cancer 37 20 28 10.1002/gcc.10186 12661002 (Pubitemid 36417918)
23. M Metzler M Wilda K Busch S Viehmann A Borkhardt 2004 High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma Genes Chromosomes Cancer 39 167 169 10.1002/gcc.10316 1:CAS:528:DC%2BD2cXjtVWqtrY%3D 14695998 (Pubitemid 38056091)
24. J Kluiver S Poppema D de Jong T Blokzijl G Harms S Jacobs BJ Kroesen, et al. 2005 BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas J Pathol 207 243 249 10.1002/path.1825 1:CAS:528:DC%2BD2MXhtFKnsr%2FI 16041695 (Pubitemid 41404155)
25. PS Eis W Tam L Sun A Chadburn Z Li MF Gomez, et al. 2005 Accumulation of miR-155 and BIC RNA in human B cell lymphomas Proc Natl Acad Sci USA 102 3627 3632 10.1073/pnas.0500613102 1:CAS:528:DC%2BD2MXisVOgsL8%3D 15738415 (Pubitemid 40354662)
26. MV Iorio M Ferracin CG Liu A Veronese R Spizzo S Sabbioni, et al. 2005 MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 7065 7070 10.1158/0008-5472.CAN-05-1783 1:CAS:528:DC%2BD2MXns1WrtL8%3D 16103053 (Pubitemid 41161233)
27. PM Voorhoeve C le Sage M Schrier AJ Gillis H Stoop R Nagel, et al. 2006 A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors Cell 124 1169 1181 10.1016/j.cell.2006.02.037 1:CAS:528:DC%2BD28Xjt1Khsrg%3D 16564011
28. T Uziel FV Karginov S Xie JS Parker YD Wang A Gajjar, et al. 2009 The miR-1792 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma Proc Natl Acad Sci USA 106 2812 2817 10.1073/pnas.0809579106 1:CAS:528:DC%2BD1MXislaht7o%3D 19196975
29. L Zhou X Qi JA Potashkin FW Abdul-Karim GI Gorodeski 2008 MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript J Biol Chem 283 28274 28286 10.1074/jbc.M802663200 1:CAS:528:DC%2BD1cXht1ans73O 18682393
30. M Nakao S Horiike Y Fukushima-Nakase M Nishimura Y Fujita M Taniwaki, et al. 2004 Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome Br J Haematol 125 709 719 10.1111/j.1365-2141.2004.04966.x 1:CAS:528: DC%2BD2cXlvFWjtLk%3D 15180860 (Pubitemid 38813597)
31. M Scherr L Venturini K Battmer M Schaller-Schoenitz D Schaefer I Dallmann, et al. 2007 Lentivirus-mediated antagomir expression for specific inhibition of miRNA function Nucleic Acids Res 35 e149 10.1093/nar/gkm971 18025036
32. LP Tan M Wang JL Robertus RN Schakel JH Gibcus A Diepstra, et al. 2009 miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes Lab Invest 89 708 716 10.1038/labinvest.2009.26 1:CAS:528:DC%2BD1MXmsVOrtb0%3D 19349957
33. GA Calin CD Dumitru M Shimizu R Bichi S Zupo E Noch, et al. 2002 Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci USA 99 15524 15529 10.1073/pnas.242606799 1:CAS:528:DC%2BD3sXjvVOl 12434020 (Pubitemid 35403967)
34. JM Trimarchi JA Lees 2002 Sibling rivalry in the E2F family Nat Rev Mol Cell Biol 3 11 20 10.1038/nrm714 1:CAS:528:DC%2BD38XhtFGmsbw%3D 11823794 (Pubitemid 135709914)
35. M Dews A Homayouni D Yu D Murphy C Sevignani E Wentzel, et al. 2006 Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat Genet 38 1060 1065 10.1038/ng1855 1:CAS:528:DC%2BD28XovVWjsbk%3D 16878133 (Pubitemid 44325933)
36. M Kato T Paranjape R Ullrich S Nallur E Gillespie K Keane, et al. 2009 The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells Oncogene 28 2419 2424 10.1038/onc.2009.106 1:CAS:528:DC%2BD1MXlsVGmsrg%3D 19421141
37. T Zenz J Mohr E Eldering AP Kater A Bühler D Kienle, et al. 2009 miR-34a as part of the resistance network in chronic lymphocytic leukemia Blood 113 3801 3808 10.1182/blood-2008-08-172254 1:CAS:528:DC%2BD1MXlt1yjsbw%3D 18941118
38. M Yamakuchi M Ferlito CJ Lowenstein 2008 miR-34a repression of SIRT1 regulates apoptosis Proc Natl Acad Sci USA 105 13421 13426 10.1073/pnas. 0801613105 1:CAS:528:DC%2BD1cXhtFChs7rO 18755897
39. AW Tong J Nemunaitis 2008 Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15 341 355 10.1038/cgt.2008.8 1:CAS:528:DC%2BD1cXlvVSmurw%3D 18369380 (Pubitemid 351693228)
40. DM Dykxhoorn D Chowdhury J Lieberman 2008 RNA interference and cancer: endogenous pathways and therapeutic approaches Adv Exp Med Biol 615 299 329 10.1007/978-1-4020-6554-5-14 18437900
41. J Stenvang S Kauppinen 2008 MicroRNAs as targets for antisense-based therapeutics Expert Opin Biol Ther 8 59 81 10.1517/14712598.8.1.59 1:CAS:528:DC%2BD2sXhsVegurvO 18081537 (Pubitemid 351233723)
42. C Blenkiron EA Miska 2007 miRNAs in cancer: approaches, aetiology, diagnostics and therapy Hum Mol Genet 16 R106 R113 10.1093/hmg/ddm056 1:CAS:528:DC%2BD2sXosFOhtL4%3D 17613543 (Pubitemid 47241849)
43. G Meister M Landthaler Y Dorsett T Tuschl 2004 Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing RNA 10 544 550 10.1261/rna.5235104 1:CAS:528:DC%2BD2cXhslOlsrw%3D 14970398 (Pubitemid 38241013)
44. S Davis B Lollo S Freier C Esau 2006 Improved targeting of miRNA with antisense oligonucleotides Nucleic Acids Res 34 2294 2304 10.1093/nar/gkl183 1:CAS:528:DC%2BD28Xks1Smt7o%3D 16690972 (Pubitemid 43985667)
45. J Takamizawa H Konishi K Yanagisawa S Tomida H Osada H Endoh, et al. 2004 Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 3753 3756 10.1158/0008-5472.CAN-04-0637 1:CAS:528:DC%2BD2cXksVKgurs%3D 15172979 (Pubitemid 38697282)
46. O Kovalchuk J Filkowski J Meservy Y Ilnytskyy VP Tryndyak VF Chekhun, et al. 2008 Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Mol Cancer Ther 7 2152 2159 10.1158/1535-7163.MCT-08-0021 1:CAS:528:DC%2BD1cXoslCnsr8%3D 18645025